Table 1.
Cells and cell lines used in this study
| Cell or cell line | Patient | mtDNA (%)
|
||
|---|---|---|---|---|
| WT | Del | Dup | ||
| 143B (ρ+) | – | 100 | 0 | 0 |
| 143B206 (ρ0) | – | 0 | 0 | 0 |
| Fibroblasts | 1 | 70 | 20 | 10 |
| KAF4EB12.22 | 1 | 100 | 0 | 0 |
| KAF4EB12.26 | 1 | 100 | 0 | 0 |
| KAF4EB12.39 | 1 | 100 | 0 | 0 |
| KAF4EB12.17 | 1 | 0 | 100 | 0 |
| KAF4EB12.49 | 1 | 0 | 100 | 0 |
| KAF4EB12.28 | 1 | 0 | 0 | 100 |
| KAF4EB12.32 | 1 | 0 | 0 | 100 |
| KAF4EB12.42 | 1 | 0 | 0 | 100 |
| 206/F4 3.13.44 | 2 | 100 | 0 | 0 |
| 206/F4 3.13.41 | 2 | 0 | 100 | 0 |
| 206/F4 3.13.46 | 2 | 0 | 100 | 0 |